NUTLEY, N.J.----Roche today announced the start of a large, multinational trial to examine a new treatment strategy in hepatitis C patients with difficult-to-treat characteristics. This study will evaluate the effect of PEGASYS® and ribavirin in patients who have a high level of genotype 1 virus in their blood and who are heavier than average in weight.
From: biz.yahoo.com
R) Trial
Posted by Ruslan Abuzant at 5:49 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment